Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3lfe | Z84 | Mitogen-activated protein kinase 14 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3lfe | Z84 | Mitogen-activated protein kinase 14 | / | 1.000 | |
| 3hv3 | R49 | Mitogen-activated protein kinase 14 | / | 0.553 | |
| 3l8s | BFF | Mitogen-activated protein kinase 14 | / | 0.540 | |
| 2bak | AQZ | Mitogen-activated protein kinase 14 | / | 0.530 | |
| 4a9y | AQZ | Mitogen-activated protein kinase 14 | / | 0.530 | |
| 2ewa | SB2 | Mitogen-activated protein kinase 14 | / | 0.519 | |
| 3gcq | 1BU | Mitogen-activated protein kinase 14 | / | 0.507 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.489 | |
| 3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.489 | |
| 3iw8 | HIZ | Mitogen-activated protein kinase 14 | / | 0.487 | |
| 2og8 | 1N8 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.483 | |
| 4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.480 | |
| 3hub | 469 | Mitogen-activated protein kinase 14 | / | 0.479 | |
| 2ejz | SAH | Diphthine synthase | / | 0.475 | |
| 3be2 | RAJ | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.475 | |
| 2oiq | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.472 | |
| 2rl5 | 2RL | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.471 | |
| 4ckr | DI1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.470 | |
| 4agw | NG7 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.466 | |
| 4bkj | STI | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.466 | |
| 2jc6 | QPP | Calcium/calmodulin-dependent protein kinase type 1D | 2.7.11.17 | 0.465 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.463 | |
| 5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.463 | |
| 1ouy | 094 | Mitogen-activated protein kinase 14 | / | 0.462 | |
| 1q5d | EPB | Epothilone C/D epoxidase | 1.14 | 0.461 | |
| 2zb1 | GK4 | Mitogen-activated protein kinase 14 | / | 0.461 | |
| 3ds6 | A17 | Mitogen-activated protein kinase 14 | / | 0.460 | |
| 4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.460 | |
| 1pkf | EPD | Epothilone C/D epoxidase | 1.14 | 0.459 | |
| 3k3e | PDB | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.459 | |
| 1blz | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.458 | |
| 2gqg | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.457 | |
| 1qiq | ACC | Isopenicillin N synthase | 1.21.3.1 | 0.456 | |
| 4jbt | ASD | Cytochrome P450 monooxygenase | / | 0.456 | |
| 1hfq | MOT | Dihydrofolate reductase | 1.5.1.3 | 0.455 | |
| 3lfc | Z86 | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 3prf | FP3 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.454 | |
| 5bp9 | SAH | Putative methyltransferase protein | / | 0.454 | |
| 3upk | UD1 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase | / | 0.453 | |
| 4kfj | 1R0 | Dihydrofolate reductase | 1.5.1.3 | 0.453 | |
| 2osc | MUH | Angiopoietin-1 receptor | 2.7.10.1 | 0.452 | |
| 2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.452 | |
| 3k4s | 0MO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.452 | |
| 2b36 | 5PP | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.451 | |
| 2p4i | MR9 | Angiopoietin-1 receptor | 2.7.10.1 | 0.451 | |
| 3b8q | 900 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.451 | |
| 2gfs | PQB | Mitogen-activated protein kinase 14 | / | 0.450 | |
| 3n3z | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.450 | |
| 4equ | G6I | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.450 | |
| 4jlj | 1NM | Deoxycytidine kinase | 2.7.1.74 | 0.450 | |
| 3uza | T4G | Adenosine receptor A2a | / | 0.450 | |
| 1pqc | 444 | Oxysterols receptor LXR-beta | / | 0.449 | |
| 2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.447 | |
| 3p99 | LNP | Lanosterol 14-alpha-demethylase | / | 0.447 | |
| 4gki | 0JN | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.447 | |
| 3gyt | DL4 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.446 | |
| 3gyu | DL7 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.446 | |
| 1uzw | CDH | Isopenicillin N synthase | 1.21.3.1 | 0.445 | |
| 3uib | SB2 | Putative mitogen-activated protein kinase | / | 0.445 | |
| 4c8b | 0LI | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.445 | |
| 4gyz | D5M | Tyrosyl-DNA phosphodiesterase 2 | 3.1.4 | 0.445 | |
| 1bk0 | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.444 | |
| 1c7o | PPG | Hemolysin | / | 0.444 | |
| 2obx | INI | 6,7-dimethyl-8-ribityllumazine synthase 2 | 2.5.1.78 | 0.444 | |
| 4b4w | 9L9 | Bifunctional protein FolD | / | 0.444 | |
| 3g4i | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.443 | |
| 3l6j | Z90 | Alr2278 protein | / | 0.443 | |
| 3pg3 | DG7 | Mitogen-activated protein kinase 14 | / | 0.443 | |
| 4few | PP2 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.443 | |
| 1obn | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.442 | |
| 4rh1 | 0TT | Spore photoproduct lyase | / | 0.442 | |
| 4twn | B96 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.442 | |
| 2pl0 | STI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.441 | |
| 3itz | P66 | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 3zoi | M2W | Isopenicillin N synthase | 1.21.3.1 | 0.441 | |
| 2iod | MYC | Dihydroflavonol 4-reductase | 1.1.1.219 | 0.440 | |
| 3qm4 | PN0 | Cytochrome P450 2D6 | / | 0.440 | |
| 4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.440 |